Featured Research

from universities, journals, and other organizations

Image-guided Treatment Helping Women With Tubo-ovarian Abscesses Avoid Unnecessary Surgery

Date:
April 23, 2009
Source:
American Roentgen Ray Society
Summary:
Image-guided drainage of tubo-ovarian abscesses help women avoid surgery, according to a study performed at Massachusetts General Hospital in Boston, Mass. Tubo-ovarian abscesses are an infected collection of pus, involving a patient's fallopian tube(s) or ovaries. They can occur in patients with complicated cases of pelvic inflammatory disease, appendicitis or diverticulitis.

Image guided drainage of tubo ovarian abscesses help women avoid surgery, according to a study performed at Massachusetts General Hospital in Boston, MA. Tubo ovarian abscesses (TOAs) are an infected collection of pus, involving a patient’s fallopian tube(s) or ovaries. They can occur in patients with complicated cases of pelvic inflammatory disease, appendicitis or diverticulitis.

The study included 54 TOAs in 46 patients. Results showed that “image guided TOA drainage avoided salpinto-oophorectomy (the surgical removal of a patient’s ovary and fallopian tube) in 95% (20/21) of pelvic inflammatory disease cases and in 72% (39/54) of cases overall,” according to Robin Levenson, MD, lead author of the study.

“Image guided drainage should be considered as an alternative to salpino-oopherectomy for the treatment of TOAs. Successful treatment of the patient’s TOA(s) and avoidance of surgery are important benefits of image guided TOA drainage,” said Dr. Levenson. “Additionally, salvation of a patient’s ovaries and fallopian tubes may preserve fertility as well as the endogenous hormones produced by the ovary,” she said.

“The procedure is quite safe. The complication rate in our series of image guided drainage of TOAs has been extremely low. Only two out of 46 (4%) patients had minor complications. No major complications occurred,” said Dr. Levenson.

“Awareness of the success of image-guided drainage in the treatment of TOAs will hopefully lead to fewer women requiring surgery and the resulting loss of their ovaries and fallopian tubes,” she said.

This study will be presented at the 2009 ARRS Annual Meeting in Boston, MA, on Tuesday, April 28.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "Image-guided Treatment Helping Women With Tubo-ovarian Abscesses Avoid Unnecessary Surgery." ScienceDaily. ScienceDaily, 23 April 2009. <www.sciencedaily.com/releases/2009/04/090423132707.htm>.
American Roentgen Ray Society. (2009, April 23). Image-guided Treatment Helping Women With Tubo-ovarian Abscesses Avoid Unnecessary Surgery. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/04/090423132707.htm
American Roentgen Ray Society. "Image-guided Treatment Helping Women With Tubo-ovarian Abscesses Avoid Unnecessary Surgery." ScienceDaily. www.sciencedaily.com/releases/2009/04/090423132707.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins